Evidence map›Paper›PMID 32474467›Full record

ArticleJournal of Alzheimer's disease : JAD2020

Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.

Wei Ling Florence Lim, Kevin Huynh, Pratishtha Chatterjee, Ian Martins, Kaushala S Jayawardana, Corey Giles, Natalie A Mellett, Simon M Laws, Ashley I Bush, Christopher C Rowe and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Sex-Specific Salivary Biochemical Composition in a Healthy Population.International journal of molecular sciences · 2026
    Article
  2. Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Age andFrontiers in aging neuroscience · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Wei Ling Florence LimSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, WA, Australia.
Kevin HuynhBaker Heart and Diabetes Institute, Melbourne, Victoria, VIC, Australia.
Pratishtha ChatterjeeSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, WA, Australia.
Ian MartinsCooperative Research Centre (CRC) for Mental Health, Australia.
Kaushala S JayawardanaBaker Heart and Diabetes Institute, Melbourne, Victoria, VIC, Australia.
Corey GilesBaker Heart and Diabetes Institute, Melbourne, Victoria, VIC, Australia.
Natalie A MellettBaker Heart and Diabetes Institute, Melbourne, Victoria, VIC, Australia.
Simon M LawsCooperative Research Centre (CRC) for Mental Health, Australia.
Ashley I BushThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, VIC, Australia.
Christopher C RoweThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, VIC, Australia.
Victor L VillemagneThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, VIC, Australia.
David AmesNational Ageing Research Institute, Parkville, Victoria, VIC, Australia.
Brian G DrewBaker Heart and Diabetes Institute, Melbourne, Victoria, VIC, Australia.
Colin L MastersThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, VIC, Australia.
Peter J MeikleBaker Heart and Diabetes Institute, Melbourne, Victoria, VIC, Australia.
Ralph N MartinsSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, WA, Australia.
AIBL research group
Baker Heart and Diabetes Institute · AUEdith Cowan University · AUThe University of Melbourne · AUMental Health Australia · AUNational Ageing Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLipid metabolism is altered in Alzheimer's disease (AD); however, the relationship between AD risk factors (age, APOEɛ4, and gender) and lipid metabolism is not well defined.

objectiveWe investigated whether altered lipid metabolism associated with increased age, gender, and APOE status may contribute to the development of AD by examining these risk factors in healthy controls and also clinically diagnosed AD individuals.

methodsWe performed plasma lipidomic profiling (582 lipid species) of the Australian Imaging, Biomarkers and Lifestyle flagship study of aging cohort (AIBL) using liquid chromatography-mass spectrometry. Linear regression and interaction analysis were used to explore the relationship between risk factors and plasma lipid species.

resultsWe observed strong associations between plasma lipid species with gender and increasing age in cognitively normal individuals. However, APOEɛ4 was relatively weakly associated with plasma lipid species. Interaction analysis identified differential associations of sphingolipids and polyunsaturated fatty acid esterified lipid species with AD based on age and gender, respectively. These data indicate that the risk associated with age, gender, and APOEɛ4 may, in part, be mediated by changes in lipid metabolism.

conclusionThis study extends our existing knowledge of the relationship between the lipidome and AD and highlights the complexity of the relationships between lipid metabolism and AD at different ages and between men and women. This has important implications for how we assess AD risk and also for potential therapeutic strategies involving modulation of lipid metabolic pathways.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseApolipoprotein E4AustraliaBiomarkersCross-Sectional StudiesFemaleFollow-Up StudiesHumansLipid MetabolismLipidomicsLipidsLongitudinal StudiesMaleRisk FactorsApolipoprotein E4BiomarkersLipidsAgingAlzheimer’s diseaseAPOEɛ4genderlipid species

Identifiers

PMID32474467
PMCPMC7369125
OpenAlexW3031826761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.